In September 2016 he presented with fever, headaches and vomiting, and thereafter received treatment in Paris for severe malaria (positive thick drop for P. falciparum with 5 parasites/2 μL, positive HRP2 antigen test) with hepatic impairment (SGOT/SGPT 92/105 U/L and hyperbilirubinaemia (93 μmol/L, normal range < 25 μmol/L) but no neurologic involvement or any other severity criteria. This evidence concerns the gene HDGFL2 and malaria.